Inflammation is associated with peripheral neuropathy, however the interplay among cytokines, chemokines, and neurons is still unclear. We hypothesized that this neuroinflammatory interaction can be defined by computational modeling based on the dynamics of protein expression in the sciatic nerve of rats subjected to chronic constriction injury. Using Dynamic Bayesian Network inference, we identified interleukin (IL)-18 as a central node associated with neuropathic pain in this animal model. Immunofluorescence supported a role for inflammasome activation and induction of IL-18 at the site of injury. Combined in vivo and in silico approaches may thus highlight novel targets in peripheral neuropathy.
Introduction
Pain arises with multiple etiologies and when pain persists beyond the natural course of tissue healing, it is considered to be chronic pain (IASP, 2003) . Chronic pain is now considered of public health importance due to its wide impact on society. Chronic pain affects around 100 million American adults and leads to economic loss of approximately $600 billion annually (IOM, 2011) . Neuropathic pain is one of the causes of chronic pain, and affects more than 6 million Americans (IOM, 2011) . Neuropathic pain occurs in response to injury of the somatosensory nervous system (Jensen et al., 2011) , and may cause pain in the joints, muscles, internal organs, or skin. Furthermore, neuropathic pain may occur in the central or peripheral nervous system based upon the site of lesion.
Following nerve injury, Wallerian degeneration or anterograde degeneration of the neurons occurs leading to disintegration of the myelin and the axons distal to the injury causing inflammation and neuropathic pain (Gaudet et al., 2011) . This axonal degeneration causes disorientation of the axon-Schwann cell organization, which initiates activation of the Schwann cells (Dubovy et al., 2014) , as well as resident immune cells including mast cells, and macrophages. Activated Schwann cells as well as the immune cells secrete chemokines and cytokines that accelerate the recruitment of other immune cells from the bloodstream. These recruited cells accumulate at the site of injury and include neutrophils, monocytes, lymphocytes, and natural killer cells (Cui et al., 2000; Monk et al., 2007; Dubovy, 2011) , likely in an attempt to promote tissue healing (Ji et al., 2014) . However, this inflammatory response often becomes self-sustaining and thus a deleterious part of the process of postinjury pain (Costigan et al., 2009 ). Indeed, due to demyelination, axonopathy, and the local inflammatory responses at the lesion, neuronal firing for the affected peripheral nerves is increased at the site of injury (peripheral sensitization). This leads to hypersensitivity or reduced threshold to a given stimuli also known as allodynia (Kajander et al., 1992; Tal and Eliav, 1996; Chen and Devor, 1998) . In the past few years, various studies have been performed to explore the molecular dialogue during inflammation following peripheral nerve injury (neuroinflammation) (Austin and Moalem-Taylor, 2010; Clark et al., 2013; Ji et al., 2014; Kiguchi et al., 2012; White et al., 2005; Zhang et al., 2013) including chronic constriction injury (CCI) rat model as developed in the 1980s (Bennett and Xie, 1988) ; however, details about the interaction among various inflammatory mediators and neurons during neuroinflammation still need to be elucidated.
Numerous immune cells and inflammatory mediators are involved at different anatomical levels in the pain axis, and hence various strategies targeting inflammation have been employed to dampen neuropathic pain (Austin and Moalem-Taylor, 2010) . One strategy is to diminish the infiltration or activation of immune cells such as mast Journal of Neuroimmunology 283 (2015) [43] [44] [45] [46] [47] [48] [49] 
